Skip to content

Clinical trials

Completed Choroidal Neovascularization trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Choroidal Neovascularization Status: Completed Country / region: United States Clear all

61 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20013
20022
20032
20042
20052
20065
200713
20087
20105
20113
20124
20131
20141
20152
20161
20172
20192
20201
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed61

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Eye Institute (NEI)10
GlaxoSmithKline5
Novartis Pharmaceuticals5
Johns Hopkins University4
Allergan3
Notal Vision Ltd.3
Graybug Vision2
Hoffmann-La Roche2
Oklahoma State University Center for Health Sciences2
Quark Pharmaceuticals2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Choroidal Neovascularization61
Macular Degeneration48
Diabetic Retinopathy4
Geographic Atrophy4
Macular Edema4
Inflammation3
Polypoidal Choroidal Vasculopathy3
Eye Diseases2
Retinal Diseases2
Retinal Vein Occlusion2

Trials

Showing 1 to 25 of 61. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.